Tweenvest Stocks

Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE: 300158)

Health Care · Pharmaceuticals · CN

CN¥5.22

-6.12% today · -41.9% 1Y

Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE: 300158) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $770.53M and employs 3,695 people.

Over the last twelve months the share price has lost 41.9%, trading between 4.47 and 10.27.

Tweenvest scores Shanxi Zhendong Pharmaceutical Co.,Ltd across four factors: quality 63/100, value 56/100, growth 0/100. Its strongest factor is quality.

300158 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$770.53M
Revenue (TTM)
$388.21M
P/E
EPS
-0.30
Dividend yield
Beta (5Y)
0.18
52-week high
CN¥10.27
52-week low
CN¥4.47
Avg volume (3M)
Shares outstanding
992.30M
Employees
3,695
Next earnings

About Shanxi Zhendong Pharmaceutical Co.,Ltd

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.

ISIN
CNE100000YR9
Founded
1995
Listed since
Jan 7, 2011
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,245.90-0.76%
Johnson & JohnsonNYSE: JNJ$651.25B$271.18+0.35%
Merck & Co., Inc.NYSE: MRK$376.37B$150.48-1.36%
Roche Holding AGSWX: ROP$373.91BCHF369.20-1.70%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£120.54-1.52%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$27.96-0.41%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.